Exploring prevalence and risk factors association of osteoporosis among chronic obstructive pulmonary disease patients: a cross-sectional study in western Rajasthan

Laxman Kumar Soni; Priyanka Soni; Praveen Kumar Garg; Daljeet Kaur; Aman Deep

doi:10.18203/2394-6040.ijcmph20242562

Authors

Laxman Kumar Soni Department of Respiratory Medicine, Government Medical College, Pali, Rajasthan, India
Priyanka Soni Department of Microbiology, Government Medical College, Pali, Rajasthan, India
Praveen Kumar Garg Department of General Medicine, Government Medical College, Pali, Rajasthan, India
Daljeet Kaur Department of Community Medicine, Government Medical College, Pali, Rajasthan, India
Aman Deep Technical Assistant, ICMR-National Institute of Cancer Prevention and Research, Noida, Delhi, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20242562

Keywords:

Bone mineral density, Chronic obstructive pulmonary disease, Osteoporosis

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition with progressive respiratory symptoms and systemic complications, including osteoporosis. It is characterized by decreased bone mass represents significant health risks among COPD patients. However, associated risk factors were partially understood requires further exploration.

Methods: Study conducted at a tertiary care hospital in western Rajasthan, India, we aimed to assess the prevalence and risk factors association of osteoporosis among COPD patients. A cross-sectional study was conducted from January 2023 to December 2023, involving 102 COPD patients by Convenience sampling categorized according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry (DEXA), and demographic and clinical data were collected.

Results: Our findings revealed high prevalence of osteoporosis (48%) among COPD patients, showed significant associations with advancing age, female sex, underweight status, and more severe COPD stages. Female gender, older age, underweight status, higher Modified Medical Research Council (mMRC) dyspnea scores, and advanced GOLD stages were identified as significant risk factors for osteoporosis.

Conclusions: These results underscore the importance of early screening and management of osteoporosis in COPD patients to mitigate its adverse effects on quality of life and morbidity. Implementing routine BMD measurements using DEXA in COPD management protocols can facilitate timely diagnosis and intervention, ultimately improving patient outcomes. Further research is warranted to elucidate the mechanistic links between COPD and osteoporosis and to explore targeted therapeutic strategies for mitigating bone loss and fracture risk in this vulnerable population.

Metrics

Metrics Loading ...

References

World Health Organization. The top 10 causes of death. Available at: https://www.who.int/news-room/factsheets/detail/the-top-10-causes-of-death. Accessed 22 January 2022.

Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2021. Available at: https://goldcopd.org/. Accessed 22 January 2022.

Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393:364-76.

Inoue D, Watanabe R, Okazaki R. COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis. 2016;11:637-48.

de Sire A, Lippi L, Aprile V, Calafiore D, Folli A, D’Abrosca F, et al. Pharmacological, nutritional, and rehabilitative interventions to improve the complex Management of Osteoporosis in patients with chronic obstructive pulmonary disease. A Narrative Review J Pers Med. 2022;12(10):1-23.

Lippi L, Folli A, Curci C, D’Abrosca F, Moalli S, Mezian K, et al. Osteosarcopenia in patients with chronic obstructive pulmonary diseases: which pathophysiologic implications for rehabilitation? Int J Environ Res Public Health. 2022;19(21):1-18.

Sarkar M, Bhardwaj R, Madabhavi I, Khatana J. Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med. 2015;9:CCRPM-S22803.

Kanis JA. On behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level: Technical report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield. UK, 2008. Available at: https://frax.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf. Accessed March 01, 2024.

Graat Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: A systematic review. Eur Respir J. 2009;34(1):209 18.

Jørgensen NR, Schwartz P. Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2008;14(2):122-7.

Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat free mass. Osteoporos Int. 2007;18:1197-202.

Biskobing DM. COPD and osteoporosis. Chest. 2002;121(2):609-20.

Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;71(3):733-8.